In esophageal adenocarcinoma (EA), the expression of UBE2C was elevated compared to Barrett's metaplasia, and was suppressed by proteasome inhibition, resulting in suppressed cell proliferation and cell cycle [24]. The gene discussed is UBE2C; the disease is esophageal adenocarcinoma.